This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Penzes P, Cahill ME, Jones KA, VanLeeuwen JE, Woolfrey KM. Dendritic spine pathology in neuropsychiatric disorders. Nat Neurosci. 2011;14:285–93.
Glausier JR, Lewis DA. Dendritic spine pathology in schizophrenia. Neuroscience. 2013;251:90–107.
Konopaske GT, Lange N, Coyle JT, Benes FM. Prefrontal cortical dendritic spine pathology in schizophrenia and bipolar disorder. JAMA Psychiatry. 2014;71:1323–31.
Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014;511:421–7.
Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177–83.
Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan CW, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214–24.
Glantz LA, Lewis DA. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65–73.
Li YF, Ma CG, Li WQ, Yang YF, Li XY, Liu JW, et al. A missense variant in NDUFA6 confers schizophrenia risk by affecting YY1 binding and NAGA expression. Mol Psychiatry. 2021; https://doi.org/10.1038/s41380-021-01125-x.
Fromer M, Roussos P, Sieberts SK, Johnson JS, Kavanagh DH, Perumal TM, et al. Gene expression elucidates functional impact of polygenic risk for schizophrenia. Nat Neurosci. 2016;19:1442–53.
Kippe JM, Mueller TM, Haroutunian V, Meador-Woodruff JH. Abnormal N-acetylglucosaminyltransferase expression in prefrontal cortex in schizophrenia. Schizophr Res. 2015;166:219–24.
Mueller TM, Haroutunian V, Meador-Woodruff JH. N-Glycosylation of GABAA receptor subunits is altered in Schizophrenia. Neuropsychopharmacology. 2014;39:528–37.
Williams SE, Mealer RG, Scolnick EM, Smoller JW, Cummings RD. Aberrant glycosylation in schizophrenia: a review of 25 years of post-mortem brain studies. Mol Psychiatry. 2020;25:3198–207.
Mealer RG, Williams SE, Daly MJ, Scolnick EM, Cummings RD, Smoller JW. Glycobiology and schizophrenia: a biological hypothesis emerging from genomic research. Mol Psychiatry. 2020;25:3129–39.
Licinio J, Wong ML. Advances in schizophrenia research: glycobiology, white matter abnormalities, and their interactions. Mol Psychiatry. 2020;25:3116–8.
Wang AM, Schindler D, Desnick R. Schindler disease: the molecular lesion in the alpha-N-acetylgalactosaminidase gene that causes an infantile neuroaxonal dystrophy. J Clin Invest. 1990;86:1752–6.
Fromer M, Pocklington AJ, Kavanagh DH, Williams HJ, Dwyer S, Gormley P, et al. De novo mutations in schizophrenia implicate synaptic networks. Nature. 2014;506:179–84.
Hall J, Trent S, Thomas KL, O’Donovan MC, Owen MJ. Genetic risk for schizophrenia: convergence on synaptic pathways involved in plasticity. Biol Psychiatry. 2015;77:52–58.
Radulescu E, Jaffe AE, Straub RE, Chen Q, Shin JH, Hyde TM, et al. Identification and prioritization of gene sets associated with schizophrenia risk by co-expression network analysis in human brain. Mol Psychiatry. 2020;25:791–804.
Kleene R, Schachner M. Glycans and neural cell interactions. Nat Rev Neurosci. 2004;5:195–208.
Scott H, Panin VM. The role of protein N-glycosylation in neural transmission. Glycobiology. 2014;24:407–17.
Park DH, Park S, Song JM, Kang M, Lee S, Horak M, et al. N-linked glycosylation of the mGlu7 receptor regulates the forward trafficking and transsynaptic interaction with Elfn1. FASEB J. 2020;34:14977–96.
Chang WP, Sudhof TC. SV2 renders primed synaptic vesicles competent for Ca2+ -induced exocytosis. J Neurosci. 2009;29:883–97.
Kwon SE, Chapman ER. Glycosylation is dispensable for sorting of synaptotagmin 1 but is critical for targeting of SV2 and synaptophysin to recycling synaptic vesicles. J Biol Chem. 2012;287:35658–68.
Yang CP, Li XY, Wu Y, Shen QS, Zeng Y, Xiong QX, et al. Comprehensive integrative analyses identify GLT8D1 and CSNK2B as schizophrenia risk genes. Nat Commun. 2018;9:838.
Acknowledgements
This study was equally supported by the Key Research Project of Yunnan Province (202101AS070055) and the Strategic Priority Research Program of the Chinese Academy of Sciences (XDPB17). Also was supported by the Distinguished Young Scientists grant of the Yunnan Province (202001AV070006), the Innovative Research Team of Science and Technology department of Yunnan Province (2019HC004), the Western Light Innovative Research Team of Chinses Academy of Sciences, the National Nature Science Foundation of China (31900414 to Y.X.H, 31970561 to X.J.L) and Henan Provincial Key Laboratory of Biological Psychiatry Open Project (ZDSYS2020002 to S.W.L). We thank Miss. Qian Li for her technical assistance.
Author information
Authors and Affiliations
Contributions
XJL conceived, designed and supervised the whole study. YFL and SWL isolated the primary rat neurons, cultured the neurons and conducted the morphological analyses (dendritic spine density of neurons). JWL performed the data analysis. YXH contributed to this work in data interpretation, data analysis and manuscript revision. YFL wrote the draft of the manuscript. XJL oversaw the project and finalized the manuscript. All authors revised the manuscript critically and approved the final version.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Li, Y., Li, S., Liu, J. et al. The schizophrenia susceptibility gene NAGA regulates dendritic spine density: further evidence for the dendritic spine pathology of schizophrenia. Mol Psychiatry 26, 7102–7104 (2021). https://doi.org/10.1038/s41380-021-01261-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41380-021-01261-4
This article is cited by
-
Genome-wide meta-analysis, functional genomics and integrative analyses implicate new risk genes and therapeutic targets for anxiety disorders
Nature Human Behaviour (2023)
-
Schizophrenia and psychedelic state: Dysconnection versus hyper-connection. A perspective on two different models of psychosis stemming from dysfunctional integration processes
Molecular Psychiatry (2023)
-
The schizophrenia-associated variant in SLC39A8 alters protein glycosylation in the mouse brain
Molecular Psychiatry (2022)